Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut

Sergio Triana(Heidelberg University), Camila Metz‐Zumaran(Heidelberg University), Carlos Ramírez(Heidelberg University), Carmon Kee(German Cancer Research Center), Patricio Doldan(German Cancer Research Center), Mohammed Shahraz(European Molecular Biology Laboratory), Daniel Schraivogel(European Molecular Biology Laboratory), Andreas R. Gschwind(Stanford University), Ashwini Kumar Sharma(Heidelberg University), Lars M. Steinmetz(European Molecular Biology Laboratory), Carl Herrmann(Heidelberg University), Theodore Alexandrov(University of California San Diego), Steeve Boulant(German Cancer Research Center), Megan L. Stanifer(Heidelberg University)
Molecular Systems Biology
April 1, 2021
Cited by 120Open Access
Full Text

Abstract

Exacerbated pro-inflammatory immune response contributes to COVID-19 pathology. However, despite the mounting evidence about SARS-CoV-2 infecting the human gut, little is known about the antiviral programs triggered in this organ. To address this gap, we performed single-cell transcriptomics of SARS-CoV-2-infected intestinal organoids. We identified a subpopulation of enterocytes as the prime target of SARS-CoV-2 and, interestingly, found the lack of positive correlation between susceptibility to infection and the expression of ACE2. Infected cells activated strong pro-inflammatory programs and produced interferon, while expression of interferon-stimulated genes was limited to bystander cells due to SARS-CoV-2 suppressing the autocrine action of interferon. These findings reveal that SARS-CoV-2 curtails the immune response and highlights the gut as a pro-inflammatory reservoir that should be considered to fully understand SARS-CoV-2 pathogenesis.


Related Papers

No related papers found

Powered by citation graph analysis